Oil Prices Hold Steady as Ukraine Tensions and Fed Cut Expectations Support Market 
IKEA Launches First New Zealand Store, Marking Expansion Into Its 64th Global Market 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
U.S. Experts to Reassess Newborn Hepatitis B Vaccination Guidelines Amid Growing Debate 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure 
Canada Loses Measles-Free Status After Nearly 30 Years Amid Declining Vaccination Rates 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Spain’s Industrial Output Records Steady Growth in October Amid Revised September Figures 
Australia Moves Forward With Teen Social Media Ban as Platforms Begin Lockouts 
South Korea will invest 274.6 billion won in the bio-industry this year for 252 new R&D projects in the four fields of biopharmaceuticals, healthcare, biomaterials, and medical equipment in 2023.
According to South Korea’s Ministry of Trade, Industry and Energy, 94.8 billion won would be allocated to developing new medicines, microbiome analysis, and other biomanufacturing process technology.
Around 69.5 billion won will support the development of advanced medical appliances, and 30 billion won will be for developing state-of-the-art biomaterials.
The ministry added that beefing up support for biomaterials and other new fields of the sector would promote innovation.
